Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01659736 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
A NA study, sponsored by Hartford Hospital.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01659736 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 26 participants.
The verdict
NCT01659736, a NA study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is investigating a new indication of Transcranial Magnetic Stimulation (TMS) by conducting a pilot randomized-controlled trial (RCT) comparing structural neuronavigation-directed TMS to Sham-TMS Placebo therapy for treatment of Generalized Anxiety Disorder (GAD).
Interventions
- DEVICE TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01659736
The ClinicalTrials.gov registry entry for NCT01659736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TMS is the first listed.
NCT01659736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01659736 about?
NCT01659736 is a clinical study titled "Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder". This study is investigating a new indication of Transcranial Magnetic Stimulation (TMS) by conducting a pilot randomized-controlled trial (RCT) comparing structural neuronavigation-directed TMS to Sham-TMS Placebo therapy for treatment of Generalized Anxiety Disorder (GAD).
What is the current status of trial NCT01659736?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2012-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01659736?
The interventions under investigation include: TMS (DEVICE).
Who is sponsoring clinical trial NCT01659736?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.